Researchers are developing new approaches to detect and treat cancer in smarter, safer and kinder ways.

With its new treatment platform for intraoperative radiotherapy, ZEISS is actively shaping the medical innovation of neuro tumor therapy. JENA, Germany, April 9, 2025 /PRNewswire/ -- As ...

As a leading provider of medical solutions in the field of neurosurgery, ZEISS Medical Technology is also dedicated to shaping modern oncology. The company recently received 510(k) clearance from the ...

In February 2017, Johnson & Johnson Innovation led a $25 million Series A funding round for Fusion Pharmaceuticals, a startup focused on targeted cancer radiotherapeutics. The funding supports its ...

In this insightful interview with B&FT and Nvame, Prof. Francis Hasford, the Director of Radiological and Medical Sciences Research Institute (RAMSRI), GAEC, offers much-needed education on the role ...

Cedric Pobel, MD, discusses how the results of the PEACE-1 trial support the use of radiotherapy plus standard of care and abiraterone in low-volume metastatic castration-sensitive prostate cancer.

Patients who develop secondary rectal cancer after receiving radiotherapy for prostate cancer have worse survival outcomes than patients with primary rectal cancer, and several factors may be driving ...

For patients with head and neck cancer (HNC), the incidence of radiotherapy-induced otitis media with effusion (RTOME) is ...

New research highlights the significance of timing and tumour location when evaluating PSMA PET scans following radiotherapy ...

Uveal melanoma, which primarily affects Caucasian patients, is the most common primary intraocular tumor in adults2 that most ...

Research institutes have pledged £5.5 million to a top team focused on developing personalized medicines for bowel cancer patients ...